Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Rapid Infuser Market Outlook

The global rapid infuser market size was valued at USD 987.7 million in 2023, driven by the increasing cases of hypothermia globally. The market size is anticipated to grow at a CAGR of 4.2% during the forecast period of 2024-2032 to achieve a value of USD 1429.9 million by 2032.

Global Rapid Infuser Market Overview

Rapid infusers are used to warm liquids in emergency medical conditions and surgeries such as haemorrhage. The rapid infuser system may continuously administer human bodily fluid in a slow to quick flow. It is typically used in emergencies to provide effective and safe therapy to patients who are suffering from severe blood loss or hypovolemic shock. There are two types of rapid infuser devices, some of them are powered by a compressor while others are connected to hospital wall-pressured outlets.

The increasing cases of hypothermia, chronic pulmonary diseases, and surgical site infections are directly contributing to the rapid infuser market growth. Rapid infusers are the most convenient and efficient means of providing bodily fluids to patients in an instant. Hence, they are extensively used in anaesthetic centres as a treatment alternative. The demand for rapid infusers is also increasing with the number of ambulatory healthcare facilities. As accident cases are rising, they directly fuel the market demand.

The market is further driven by the rising research activities to improve the efficacy of rapid infusers. There is a growing integration of advanced technologies, expected to propel the market expansion. The market may also be influenced by increased competition among companies providing devices with enhanced features that minimize negative effects on blood components.

Surge in FDA Approvals to Meet the Rising Rapid Infuser Market Demand

In August, 2023, ICU Medical Inc., a worldwide leader in the development, manufacture, and sale of innovative medical devices, announced that the company has received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Duo infusion pump with LifeShield infusion safety software. The Plum Duo pump and LifeShield software will be made available to customers in the United States by early 2024.

This approval marks a significant milestone for ICU Medical Inc. and exhibits their dedication to providing safe and advanced medical devices. The market is expected to be bolstered by this FDA approval as it will provide healthcare professionals with a technologically advanced and safe solution in the form of the Plum Duo infusion pump, along with an additional layer of safety with LifeShield infusion safety software.

Innovative Product Launches to Boost the Rapid Infuser Market Share 

In April 2023, Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions with reliable innovations, announced the launch of its new cutting-edge connected infusion multi-therapy ambulatory infusion system – Avoset™. It is designed to transform post-acute care and specialty infusion therapy with compact and simplified technology that can monitor infusion treatment data remotely, aiming to enhance patient safety and improve the user experience.


 
The Avoset™ Infusion Platform complements the Sapphire Infusion portfolio and is especially well positioned to address infusion needs for therapies that require secure medication reservoirs and a long battery life at low flow rates. The Avoset Infusion Pump is MDR certified and is currently available in selected European countries.   The major offering of the product is its ability to monitor infusion treatment data remotely, allowing healthcare professionals to keep track of patient progress and enhance it. This will result in increased adoption of the system by healthcare professionals in clinical settings, contributing to the increased demand, and propelling the rapid infuser market size.

Additionally, in January 2024, Switzerland-based medical devices maker PharmaSens applied for US Food and Drug Administration (FDA) for its ‘niia essential’ insulin patch pump system. It is a significant move for PharmaSens as it is an advancing insulin pump technology, also claimed to be one of the most compact patch pumps available. It incorporates an automatic needle insertion mechanism, ensuring the safety of the 90° steel needle. The semi-reusable concept of the insulin pump system aligns with cost-efficiency and sustainable design, meeting the demand for environmentally friendly products.  These features could be the major reason for the increased adoption of this system in the forecast period.

Global Rapid Infuser Market Segmentation

Market Breakup by Type

  • Trolley Mounted Devices
  • Handheld Devices

Market Breakup by Usability
 

  • Single Use
  • Reusable

Market Breakup by Applications

  • Cancer
  • Diabetes
  • Pediatric
  • Others

Market Breakup by End Users

  • Hospitals
  • Ambulatory Services
  • Specialty Clinics
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Rapid Infuser Market Regional Analysis

Geographically, North America is leading the global market rapid infuser market share and is expected to lead throughout the forecast period. This is due to access to advanced and innovative technologies associated with healthcare and effective healthcare regulations, contributing to the market growth in the region.

In November 2023, 410 Medical, Inc., focused on early resuscitation of emergency patients with shock and hypotension, announced the completion of an Air Force AFWERX Phase II SBIR Award to advance the development of LifeFlow Ultra. This innovative ultra-compact rapid infuser is designed for operational environments where space, weight, and power supply are at an absolute premium. Like the currently marketed LifeFlow PLUS, LifeFlow Ultra will enable healthcare providers to transfuse blood and IV fluids quickly for patients with hemorrhagic shock.

By promising efficiency in transfusing blood and IV fluids quickly for patients experiencing hemorrhagic shock LifeFlow Ultra has positioned itself among the key players in the market. This offering also makes them stand out as a valuable addition to the existing market, boosting the global rapid infuser market value.

Global Rapid Infuser Market: Competitor Landscape

In July 2023, BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the updated BD Alaris™ Infusion System received 510(k) clearance from the U.S. Food and Drug Administration (FDA), which enables both remediation and a return to full commercial operations for the most comprehensive infusion system available in the United States.

This clearance covers updated hardware features for Point-of-Care Unit (PCU), large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. It also covers a new BD Alaris™ Infusion System software version with enhanced cybersecurity, along with interoperability features that enable smart, connected care with the most widely used electronic medical record (EMR) systems.

The key features of the rapid infuser market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Becton, Dickinson and Company (BD)
  • B. Braun Melsungen AG
  • Smiths Medical (A division of Smiths Group)
  • 3M Company
  • Teleflex Incorporated
  • Fresenius Kabi AG
  • Stryker Corporation
  • Smith Medical
  • ZOLL Medical Corporation
  • GE Healthcare
  • Baxter International Inc.
  • Halyard Health
  • Ivenix, Inc.
  • AngioDynamics, Inc.
  • FiPerSys Medical

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Usability
  • Applications
  • End Users
  • Region
Breakup by Type
  • Trolley Mounted Devices
  • Handheld Devices
Breakup by Usability
  • Single Use
  • Reusable
Breakup by Applications
  • Cancer
  • Diabetes
  • Pediatric
  • Others
Breakup by End Users
  • Hospitals
  • Ambulatory Services
  • Specialty Clinics
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Becton, Dickinson and Company (BD)
  • B. Braun SE
  • Smiths Group Plc. 
  • 3M
  • Teleflex Incorporated
  • Fresenius Kabi AG
  • Stryker Corporation
  • Biegler GmbH 
  • ZOLL Medical Corporation
  • GE Healthcare
  • Baxter 
  • Halyard Health
  • Fresenius Kabi AG 
  • Angio Dynamics 
  • PerSys Medical

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 987.7 million in 2023 driven by the increased surgical site infection cases.

The market is anticipated to grow at a CAGR of 4.2% during the forecast period of 2024-2032 and is likely to reach a market value of USD 1429.9 million by 2032.

 The rise in hypothermia cases, expanded utilization of rapid infusers in multiple areas and increasing advancements in technology such as enhanced accuracy are directly contributing the market demand. 

The surge in FDA approvals for new products, emphasized at offering improved outcomes is a major market trend. In August 2023, the FDA granted 510(k) regulatory clearance to ICU Medical's Plum Duo infusion pump with LifeShield infusion safety software.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Types of infusers in the market include trolley-mounted devices and handheld devices.

 Rapid infusers offer single-use and reusable usability. 

They find applications in cancer, diabetes, and pediatrics among others.

The end users include hospitals, ambulatory services, and specialty clinics among others.

Key players involved in the market are Becton, Dickinson and Company (BD), B. Braun Melsungen AG, Smiths Medical (A division of Smiths Group), 3M Company, Teleflex Incorporated, Fresenius Kabi AG, Stryker Corporation, Smith Medical, ZOLL Medical Corporation, GE Healthcare, Baxter International Inc., Halyard Health, Ivenix, Inc., AngioDynamics, Inc. and FiPerSys Medical.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124